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1. INTRODUCTION 2. MATERIALS AND METHODS 
An important regulator of the catalytic proper- 
ties of H + -ATPase is a low Mr protein, originally 
[1] from bovine heart mitochondria. This protein 
was later isolated from chloroplasts [2], bacteria 
[3], yeast [4,5], and liver [6,7]. Although the inhibit- 
ing action of the protein on the hydrolytic proper- 
ties of H +-ATPase (review [8]) as well as of all the 
ATP-dependent reactions of mitochondria [9,10] 
has been long known, the protein was only re- 
cently observed to affect the synthesis of ATP in 
chloroplasts [11], heart [12,13] and liver [14] mito- 
chondria. 
A partial [15] and complete [16] amino acid se- 
quence of the inhibitor protein from heart was re- 
ported by 2 independent groups. Although both 
preparations had an identical sequence of 8 amino 
acids in a segment of the protein, wide differences 
were found in the rest of the 2 proteins that were 
analyzed. As the 2 inhibitor proteins were pre- 
pared by different methodologies, mitochondria 
may possess more than one type of inhibitor pro- 
tein. 
Here, a comparison of the inhibition of ATPase 
activity by inhibitor proteins from yeast [5], heart 
[18,19] and liver [6,7] prepared by 2 different 
methods was made, using ATPase from heart, liver 
and yeast as target enzymes. We also studied 
whether antibodies directed against the inhibitor 
protein in [19] or the yeast inhibitor in [5] cross- 
reacted with other inhibitor protein preparations. 
Mitochondria from bovine heart were prepared 
as in [20]. Mitochondria from rat-livers were pre- 
pared in 0.25 M sucrose and 1 mM EDTA by stan- 
dard centrifugation techniques, while mitochon- 
dria from yeast were obtained from Saccharomyces 
cerevisiae strain D311-3A grown to the late station- 
ary phase in media that contained 1% yeast extract 
(Difco), 2% Bacto-Peptone, 4% glycerol and 3% 
ethanol; the mitochondria from these cells were 
obtained according to [21]. Ammonia-Sephadex 
(A-S) submitochondrial particles from yeast 
passed through a Sephadex column were prepared 
as in [18], [22] and [23], respectively. 
2.1. Preparation of inhibitor proteins and anti- 
bodies. 
For the heart inhibitor proteins, the methods in 
[18,19] were followed. For the protein from liver, 
the methods in [6,7] were used, the latter to the 
step prior to Sephadex-sand chromatography. 
The inhibitor protein from yeast was obtained as 
in [5]. Antibodies against he bovine heart inhibi- 
tor protein [19] were prepared as in [24]; the same 
method was used to prepare antibodies against he 
yeast inhibitor protein [5]. 
2.2. Assays 
Inhibitory action of inhibitor proteins was as- 
sayed by incubating them with submitochondrial 
particles from various sources in 100/~1 10 mM 
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Fig.l. Gel electrophoresis of the inhibitor proteins. The analysis was done as in section 2: H-HR, heart [18]; H-KS, 
heart [19]; Y, yeast; L-I, liver [6]; L-2, liver [14]. The arrows indicate the top of the gel (left-arrow) and the dye front. 
Tris-MES and 250tLM Mg-ATP at pH 6.6 for 
10 min at 30°C. Aliquots were withdrawn to esti- 
mate ATP hydrolysis by recording NADH oxida- 
tion in an ATP regenerating system [25]. 
Ouchteriony plates [26] were used to test the im- 
munological cross-reactivity of the various inhibi- 
tor proteins with antibodies prepared from either 
bovine hearts and yeast. SDS slab gel electropho- 
resis was done following [27], in 20% acrylamide. 
The gels were stained with 0.25% Coomassie blue 
R-250 and destained with 20% methanol and 7.5% 
acetic acid. Scanning of the gels was made with a 
gel scanner Mod. 1310 ISCO with absorbance 
monitor ldN-5. Protein of mitochondria and parti- 
cles was determined by the biuret method, that of 
inhibitor protein and antibodies according to [28]. 
Bovine serum albumin was used as standard. 
3. RESULTS 
The electrophoretic analysis of the inhibitor pro- 
teins from heart showed only one component 
(fig.l). The proteins from liver prepared according 
to [6,7] were contaminated with other proteins; in 
the former a high-Mr protein was the main con- 
taminant. The inhibitor protein from yeast was 
slightly contaminated with 2 low-Mr proteins. 
In Ouchterlony plates, antibodies against the 
heart inhibitor protein [19] produced a precipita- 
tion band with the 2 inhibitor proteins from heart 
[18,19]; moreover, the proteins tested showed im- 
munological identity (fig.2). These antibodies 
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Fig.2. Immunodiffusion tests of antibodies formed from heart and yeast inhibitor proteins against inhibitor proteins 
from various sources. In all plates, the center well contained antibodies against the heart inhibitor [19] or antibodies 
against he yeast inhibitor; these are marked H and Y, respectively. The following amounts of antibodies were placed in
the center wells: plate I- IV, VII, 0.5 mg; plates IV, VI, 1 mg. Also in all plates, the wells marked 1 contained 25 #g 
homologous inhibitor protein. In the rest of the wells, the following inhibitor proteins at various dilutions were placed. 
Plate: I, yeast inhibitor (1.6-30 t~g); II, heart inhibitor [19] (1.4-23/~g); 11I, liver inhibitor [6] (1.8-29/~g); IV, liver 
inhibitor [6] (1.8-29 ~g); V, liver inhibitor 17] (3.3-53 t~g); VI, liver inhibitor [7] (3.3-53/~g); VII, wells 1, 4 contained 
70/~g heart inhibitor I18]; wells 2, 5 contained 23/zg heart inhibitor [19]. 
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Fig.3. The inhibiting action of various inhibitor proteins on the ATPase activity of submitochondrial particles from 
various sources. The effect of the indicated amounts of inhibitor proteins were tested as in section 2 on the indicated 
submitochondrial particles (SMP). LI and L2 inhibitor proteins from liver [6,14]; Y, yeast inhibitor; H, the heart 
inhibitor [19]. 
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failed to react with the protein from yeast, or from 
liver when the latter were tested over a wide con- 
centration range. Antibodies against the inhibitor 
protein from yeast reacted with the yeast inhibitor 
(fig. 2) but not with the proteins from heart and 
liver (fig.2). 
Fig.3 shows that all the proteins inhibit the hy- 
drolytic activity of all the ATPase tested. The pro- 
teins from heart and yeast seem to be equally 
effective in the inhibition of catalytic activity re- 
gardless of the source of the enzyme (fig.3). The 
liver proteins, notwithstanding the method of 
preparation are less effective, not only when tested 
in the heart and yeast enzyme (fig.3A,C), but also 
in the enzyme from liver (fig.3B). The inhibitor 
proteins of heart prepared according to [18,19] 
showed almost the same degree of effectiveness in 
inhibiting ATPase activity of heart, liver and yeast 
(not shown). 
4. DISCUSSION 
The inhibitor proteins of heart prepared accord- 
ing to [18,19] inhibit ATPase activity of the ATP- 
ases of liver, y~ast and heart very similarly. They 
also show immunological identity, and would ap- 
pear to be the same protein. Therefore, it is very 
difficult to explain why the reported amino acid 
sequence [15] differs from that in [16], even though 
a segment of 8 amino acids is identical in both 
preparations. Moreover, the findings in [16] also 
contrast with [29] where, in the inhibitor protein 
from heart, most of the basic amino acids were 
found clustered in the C-terminal region. 
The yeast and the heart inhibitors inhibit very 
effectively and very similarly the ATPase activity 
of the various ATPase tested. The amino acid se- 
quence of the yeast inhibitor has also been deter- 
mined [30]. A comparison of the sequence of heart 
[16] and yeast [30] proteins shows clusters of 
charged amino acids, and a segment in which the 
sequence is almost identical; i.e., 38-42 and 40-44 
in the heart and yeast proteins, respectively. There- 
fore it is possible that these proteins exert their in- 
hibiting action through these regions. The amino 
acid sequences of the rest of the yeast and heart 
protein appear to be very different, and this most 
certainly accounts for their different immunologi- 
cal characteristics. 
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